4.0 Article

Apheresis practice patterns in the United States of America: Analysis of a market claims database

Journal

JOURNAL OF CLINICAL APHERESIS
Volume 36, Issue 5, Pages 750-758

Publisher

WILEY
DOI: 10.1002/jca.21926

Keywords

database; International Classification of Diseases; Ninth version; plasma exchange; red blood cell exchange

Categories

Funding

  1. Masonic Cancer Research Fund
  2. National Center for Advancing Translational Sciences [UL1TR002494]
  3. University of Minnesota, Department of Laboratory Medicine and Pathology

Ask authors/readers for more resources

This study analyzed the patterns and situations of apheresis procedures using health insurance claims data from large employers and health plans across the United States. A wide variety of diagnoses were treated through apheresis, but some procedure codes may not accurately reflect the nature of the procedures. The study highlights the need for direct measurement of apheresis procedures for future research studies.
Introduction Indications for apheresis procedures are expanding; however, the evidence for many is low quality. A better understanding of apheresis patterns in the United States is needed to better plan prospective research studies. Methods Data from January 1, 2013, to September 30, 2015, were analyzed from the IBM MarketScan Research Databases of de-identified health insurance claims data of several million enrollees at all levels of care from large employers and health plans across the United States. Apheresis procedures were identified by International Classification of Diseases, Ninth version (ICD-9) and Current Procedure Terminology (CPT) codes. Results Combining inpatients and outpatients, 18 706 patients underwent 70 247 procedures. The patients were 52.7% female, 5.1% <18 years, and 55.9% inpatient, while the procedures were 49.5% female, 5.7% <18 years, and 19.8% inpatient. For each apheresis modality, the percent of patients treated and procedures performed, respectively, are plasmapheresis 36.4% and 42.5%, autologous harvest of stem cells 22.8% and 10.7%, plateletpheresis 11.1% and 3.5%, allogeneic harvest of stem cells 8.2% and 2.5%, photopheresis 5.4% and 24.4%, erythrocytapheresis 3.8% and 4.7%, leukopheresis 2.0% and 0.7%, immunoadsorption 1.4% and 0.4%, extracorporeal selective adsorption/filtration and plasma reinfusion 1.0% and 3.6%, and other 21.6% and 6.9%. A wide variety of diagnoses were treated; however, analysis of the diagnoses suggests the procedure codes may not always reflect an apheresis procedure. Conclusion This study describes the landscape of apheresis in the United States, but may overestimate some procedures based on linked diagnosis codes. Direct measures of apheresis procedures are needed to plan future research studies.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.0
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available